1. Home
  2. LAB vs TCPC Comparison

LAB vs TCPC Comparison

Compare LAB & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • TCPC
  • Stock Information
  • Founded
  • LAB 1999
  • TCPC 2006
  • Country
  • LAB United States
  • TCPC United States
  • Employees
  • LAB N/A
  • TCPC N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • TCPC Finance/Investors Services
  • Sector
  • LAB Industrials
  • TCPC Finance
  • Exchange
  • LAB Nasdaq
  • TCPC Nasdaq
  • Market Cap
  • LAB 449.9M
  • TCPC 478.8M
  • IPO Year
  • LAB 2011
  • TCPC 2012
  • Fundamental
  • Price
  • LAB $1.23
  • TCPC $5.65
  • Analyst Decision
  • LAB Hold
  • TCPC Sell
  • Analyst Count
  • LAB 2
  • TCPC 2
  • Target Price
  • LAB $1.35
  • TCPC $6.50
  • AVG Volume (30 Days)
  • LAB 1.5M
  • TCPC 611.0K
  • Earning Date
  • LAB 11-04-2025
  • TCPC 11-06-2025
  • Dividend Yield
  • LAB N/A
  • TCPC 21.63%
  • EPS Growth
  • LAB N/A
  • TCPC N/A
  • EPS
  • LAB N/A
  • TCPC N/A
  • Revenue
  • LAB $169,737,000.00
  • TCPC $219,119,058.00
  • Revenue This Year
  • LAB N/A
  • TCPC N/A
  • Revenue Next Year
  • LAB N/A
  • TCPC N/A
  • P/E Ratio
  • LAB N/A
  • TCPC N/A
  • Revenue Growth
  • LAB 79.77
  • TCPC N/A
  • 52 Week Low
  • LAB $0.92
  • TCPC $5.39
  • 52 Week High
  • LAB $2.25
  • TCPC $9.72
  • Technical
  • Relative Strength Index (RSI)
  • LAB 48.04
  • TCPC 42.71
  • Support Level
  • LAB $1.16
  • TCPC $5.60
  • Resistance Level
  • LAB $1.26
  • TCPC $5.91
  • Average True Range (ATR)
  • LAB 0.07
  • TCPC 0.15
  • MACD
  • LAB 0.01
  • TCPC 0.03
  • Stochastic Oscillator
  • LAB 72.50
  • TCPC 31.31

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

Share on Social Networks: